Pivotal bioVenture Partners, established in 2017, is a San Francisco-based venture fund that focuses on investing in early-stage biotechnology companies. The fund, led by Partner Wendy Ardrey, is active in funding companies across various stages from Pre-Seed to Series D. With a specific focus on the Life Science and BioTech sectors, Pivotal bioVenture Partners has made 27 investments and has seen 14 successful exits. For more information about their investment criteria and portfolio companies, visit their website at www.pivotalbiovp.com.